XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
XW004 is an acylated human glucagon-like peptide 1 (GLP-1) analogue and is being developed for type 2 diabetes mellitus (T2DM) and obesity management.
Epistemonikos ID: 7437714ae1260d69e846eb7d8541e6f01548b207
First added on: May 09, 2024